Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LIFE
LIFE logo

LIFE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ethos Technologies Inc (LIFE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
16.010
1 Day change
-1.17%
52 Week Range
19.000
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ethos Technologies Inc (LIFE) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, and a unique competitive position in the life insurance market. Despite technical indicators showing overbought conditions, the long-term growth potential outweighs short-term volatility concerns.

Technical Analysis

The MACD histogram is positive and expanding, indicating bullish momentum. RSI is at 92.89, signaling overbought conditions, which could suggest a potential pullback in the short term. Moving averages are converging, and the stock is trading near resistance levels (R1: 15.156, R2: 16.265).

Positive Catalysts

  • Strong financial performance in Q4 2025 with significant YoY growth in revenue (+65.47%), net income (+157.24%), and EPS (+160%). Analysts have consistently raised price targets, citing Ethos' disruptive technology and competitive advantages in the life insurance market. Positive sentiment from multiple analysts with Buy or Outperform ratings.

Neutral/Negative Catalysts

  • RSI indicates overbought conditions, suggesting a potential short-term pullback. No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In Q4 2025, revenue increased to $110.08M (+65.47% YoY), net income rose to $24.56M (+157.24% YoY), and EPS grew to $0.39 (+160% YoY). Gross margin improved slightly to 96.96%, reflecting strong profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive, with multiple Buy and Outperform ratings. Recent price target increases include BofA ($18), Deutsche Bank ($24), Citi ($16), and Goldman Sachs ($33). Analysts highlight Ethos' strong growth potential, unique technology stack, and competitive advantages in the life insurance market.

Wall Street analysts forecast LIFE stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast LIFE stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 16.200
sliders
Low
0
Averages
0
High
0
0
Current: 16.200
sliders
Low
0
Averages
0
High
0
BofA
Buy
maintain
$15 -> $18
AI Analysis
2026-02-26
Reason
BofA
Price Target
$15 -> $18
AI Analysis
2026-02-26
maintain
Buy
Reason
BofA raised the firm's price target on Ethos to $18 from $15 and keeps a Buy rating on the shares following a "clean beat & raise" report in first quarter out of the gate since the company came public. Management addressed AI risk, citing cost benefits to engineering, marketing, agent service, and fraud management, while emphasizing that regulatory complexities and the data moat limit AI-native competitive entrants, the analyst tells investors.
Deutsche Bank
Lee Horowitz
Buy
maintain
$23 -> $24
2026-02-26
Reason
Deutsche Bank
Lee Horowitz
Price Target
$23 -> $24
2026-02-26
maintain
Buy
Reason
Deutsche Bank analyst Lee Horowitz raised the firm's price target on Ethos to $24 from $23 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LIFE
Unlock Now

People Also Watch